Biophotonic markers of malignancy: Discriminating cancers using wavelength-specific biophotons.

ABSTRACT: Early detection is a critically important factor when successfully diagnosing and treating cancer. Whereas contemporary molecular techniques are capable of identifying biomarkers associated with cancer, surgical interventions are required to biopsy tissue. The common imaging alternative, positron-emission tomography (PET), involves the use of nuclear material which poses some risks. Novel, non-invasive techniques to assess the degree to which tissues express malignant properties are now needed. Recent developments in biophoton research have made it possible to discriminate cancerous cells from normal cells both in vitro and in vivo. The current study expands upon a growing body of literature where we classified and characterized malignant and non-malignant cell types according to their bio

SUBMITTER: Murugan NJ 

PROVIDER: S-EPMC5699883 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature